Showing 2,658 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Activism & civil society

Building patient groups for viral hepatitis – a new online resource for healthcare professionals

Editor's pick
BMC Blogs Network (blog)
22 January 2016
Hepatitis C symptoms & diagnosis

Cardiovascular disease risk is higher for people with hepatitis C

News
22 January 2016
Side effects

D:A:D study: long-term treatment with tenofovir associated with increased risk of serious liver disease

News
21 January 2016
Hepatitis C symptoms & diagnosis

Hepatitis Testing Contest

Editor's pick
Social Entrepreneurship for Sexual Health
19 January 2016
New & experimental hepatitis C treatment

The 2016 Hepatitis C Drug Approval Outlook

Editor's pick
Poz
18 January 2016
Harm reduction

European Union Joint Action on HIV and Co - infection Prevention and Harm Reduction launched

Editor's pick
Manual Items
18 January 2016
Cancer

High rates of modifiable cancer risk factors present in Western HIV-positive patients

News
18 January 2016
Side effects

Viread (Tenofovir, TDF) Linked With Liver Disease and Cancer

Editor's pick
Poz
14 January 2016
New & experimental hepatitis C treatment

AbbVie Initiates Enrollment of Six Global Phase 3 Clinical Studies for Once-Daily, Pan-Genotypic Hepatitis C Regimen

Editor's pick
AbbVie press release
11 January 2016
Neurological & cognitive problems

Hepatitis C virus linked to increased risk of Parkinson's disease, studies show

News
11 January 2016
New & experimental hepatitis C treatment

Mylan Launches Generic Harvoni® (Ledipasvir/Sofosbuvir) Under the Brand Name MyHep LVIR™ in India

Editor's pick
Mylan press release
8 January 2016
Hepatitis B

J&J signs deal with Chinese company for hepatitis B drug

Editor's pick
Reuters
8 January 2016
New & experimental hepatitis C treatment

Inside the hepatitis C virus is a promising antiviral

Editor's pick
Medical Xpress
6 January 2016
New & experimental hepatitis C treatment

Gilead Announces U.S. FDA Priority Review Designation for Sofosbuvir/Velpatasvir for Treatment of All Genotypes of Chronic Hepatitis C Infection

Editor's pick
Gilead press release
5 January 2016
Hepatitis C treatment

The drug that costs more than $1200, and sells for $5 in India

Editor's pick
Sydney Morning Herald
3 January 2016
Hepatitis C transmission & prevention

'Half' of injecting drug users in Wales at Hepatitis C risk

Editor's pick
BBC News
3 January 2016
Hepatitis C treatment

DAAs could halt HCV epidemic in US – but only with near-universal testing and big increase in treatment rates

News
30 December 2015
Hepatitis C treatment

A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir, says US study, but most successfully appeal

News
29 December 2015
Drug interactions & pharmacokinetics

Many patients on new HCV medications at risk of drug-drug interactions

Editor's pick
Medscape (requires free registration)
23 December 2015
Hepatitis C treatment

Australia: People Who Use Drugs Welcome Decision to ‘Seize the Day’ on New Hepatitis C Treatments

Editor's pick
Australian Injecting & Illicit Drug Users League
21 December 2015
Hepatitis C treatment

Concern over hepatitis C drug costs only the beginning, health officials say

Editor's pick
The News Tribune
21 December 2015
Hepatitis C treatment

Hopes Hepatitis C could be wiped out in Australia as the Federal Government pledges $1b to subsidise 'breakthrough' cures

Editor's pick
9news.com.au
21 December 2015
Hepatitis C transmission & prevention

Hepatitis C prevention, control efforts should focus on incarcerated individuals

Editor's pick
EurekAlert (press release)
17 December 2015
Access to healthcare

Curing Hepatitis C, in an Experiment the Size of Egypt

Editor's pick
New York Times
16 December 2015